HROW

Harrow Health Inc.

Price

$41.64

return (12m)

8.92%

p/e

-40.03

p/bv

100.34

DIVIDEND YIELD

0.00%

HROW price

Harrow Health

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment HROW

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-7.62%

3 months

26.33%

1 year

8.92%

2 years

5.47%

5 years

328.84%

10 years

1,022.37%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals HROW

Valuation

P/E

-40.03

Sector -2.19

Industry 1.21

P/BV

100.34

Sector 2.22

Industry 2.11

P/Revenue (PSR)

5.41

Sector 2.01

Industry 0.78

EV/EBITDA

-352.38

Sector -17.81

Industry -25.30

EV/EBIT

-154.27

Sector -26.72

Industry -18.04

P/EBITDA

130.82

Sector 0.36

Industry 0.18

P/EBIT

-142.58

Sector -3.34

Industry 1.26

P/Total Assets

3.57

Sector 1.23

Industry 0.86

P/Net Current Assets

-8.63

Sector -27.35

Industry -12.37

P/Working Capital

11.72

Sector -4.54

Industry -49.48

EPS

-1.01

Sector -0.87

Industry -0.55

BVPS

0.40

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

73.28%

Sector 43.36%

Industry 31.53%

EBITDA Margin

-6.82%

Sector -323.65%

Industry -73.39%

EBIT Margin

-15.58%

Sector -194.57%

Industry -11.94%

Operating Margin

-1.00%

Sector -24.37%

Industry -9.87%

Net Profit Margins

-13.51%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.17

Sector 0.12

Industry 0.22

Profitability

ROE

-250.64%

Sector -33.82%

Industry -37.56%

ROA

-8.93%

Sector -29.63%

Industry -17.56%

ROIC

-18.88%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.24

Sector 1.84

Industry 1.14

Net Debt / EBITDA

-43.26

Sector -1.47

Industry -31.86

Net Debt / EBIT

-18.94

Sector -1.32

Industry 2.06

Net Debt / Equity

14.04

Sector -0.35

Industry 0.14

Gross Debt / Equity

19.69

Sector 0.14

Industry 0.51

Equity/Assets

0.04

Sector 0.42

Industry 0.25

Liabilities/Assets

0.96

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

30.62%

Sector -

Industry -

5Y Earnings CAGR

15.63%

Sector -

Industry -

Fundamentals HROW

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
HROW Harrow Health Inc.	$41.64	8.66%	0.00%	-40.03	100.34	-250.64%	-13.51%
LLY Eli Lilly and Compay	$1,280.34	83.05%	0.54%	39.62	31.24	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
SNY Sanofi	$45.83	-4.42%	4.04%	7.10	1.31	18.43%	13.81%
NVS Novartis AG	$160.31	31.78%	2.05%	22.57	6.87	30.41%	22.50%
TMO Thermo Fisher Scientific Inc.	$613.54	26.39%	0.30%	31.58	4.17	13.19%	15.04%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
GSK GlaxoSmithKline PLC	$52.88	41.51%	3.59%	15.15	4.28	28.24%	14.54%
CVS CVS Health Corporation	$93.65	37.68%	2.73%	25.48	1.56	6.12%	1.18%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
DHR Danaher Corporation	$211.50	0.79%	0.71%	35.81	2.73	7.61%	15.95%
HCA HCA Healthcare Inc.	$407.05	4.09%	0.74%	13.12	-27.97	-213.15%	8.77%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

HROW Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Harrow Health

Harrow Health Inc.

Average Investor10 user rating

4.0 (2 people)

United States

20 years

Founded: 2006

2007

Time since IPO - 19 years

125

Employees

Harrow Health Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.49 billion, with shareholders equity totaling $14.85 million.

The company employs approximately 125 people and operates in the Health sector, within the Main Medications industry.

Over the past 12 months, Harrow Health Inc. reported $275.59 million in revenue, generating net income of $-37.22 million.

Key financial metrics include a P/E ratio of -40.03, a price-to-book (P/B) ratio of 100.34, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker HROW.

Market cap

$1.49 billion

Net worth

$14.85 million

$14,850,000.00

Assets

$416.82 million

$416,820,000.00

Total Shares Outstanding

37.00 million

37,000,000

Average Daily Trading Volume

$688.75 Thousand

$688,750.00

Sector

Health

Industry

Main Medications

HROW

HROW revenue and profits

Financial Results HROW

DRAG THE FRAME TO SEE MORE DATA

HROW cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87